In Vitro Fertilization Market

In Vitro Fertilization Market Size and Share:

The global in vitro fertilization market size was valued at USD 26.20 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 50.86 Billion by 2033, exhibiting a CAGR of 7.27% during 2025-2033. Europe dominates the market in 2024 with 37.6% of the market share. The major drivers of the market include the increasing rates of infertility, numerous advancements in reproductive technologies, the growing awareness regarding fertility treatments among consumers, the emerging trend of delayed parenthood, the expanding number of fertility clinics, the implementation of supportive government initiatives, and continually improving healthcare infrastructure, especially in emerging economies.

The global market is majorly driven by the considerable rise in the infertility rates along with a higher prevalence of lifestyle disorders. Moreover, delayed parenthood due to changing lifestyles is acting as a significant growth inducing factor for the market. Moreover, increasing societal acceptance regarding assisted reproductive technologies is also providing an impetus to the market. Notably, as per a research article published on 13 March 2024, delayed parenting in affluent societies is caused by rising income expectations and not economic uncertainty. The study finds that although increased income requirements push back the timing of parenthood, fears of economic instability are of little significance. The research shows that the impact of income on the probability of a first child has increased over time, changing patterns of fertility around the world for both men and women. Additionally, supportive policies and funding from governments and healthcare organizations is further fostering accessibility, thereby contributing to the market growth. Numerous innovations, such as better embryo freezing techniques and preimplantation genetic testing, increasing success rates, is making adoption more appealing, which in turn is supporting the market. Also, increasing medical tourism, especially in regions with cost-effective treatments, is propelling the market's reach, thereby opening opportunities for established players as well as new entrants.

The United States stands out as a key regional market, driven by the increasing infertility rates, delayed parenthood, rising awareness about assisted reproductive technologies, and advancements in medical procedures. For instance, according to a report released on April 10, 2024, the average age of first-time mothers in the United States has risen to a record high of slightly over 27. Delays in marriage, schooling, and professional priorities are some of the causes of this. Women and men are delaying having children, often due to financial reasons or societal pressures. However, waiting can result in fertility problems and health issues. Assisted reproductive technology is becoming increasingly popular but expensive and not guaranteed. While delaying parenthood can have benefits, it also raises questions about societal structures and access to resources. As of 2023, 42% of Americans reported either personally using or knowing someone who had utilized fertility treatments, representing an increase from 33% reported five years prior. Moreover, ongoing technological innovations, including time-lapse imaging and genetic testing, are further improving treatment efficiency and outcomes, thereby providing a boost to the market. Additionally, government’s favorable reimbursement policies for infertility treatments are also fostering market adoption.

In Vitro Fertilization Market Trends:

Growing Integration of Genetic Screening Technologies

Integration of genetic screening technologies in the industry has taken place rapidly with the most dominant being preimplantation genetic testing (PGT). The report from IMARC Group points out that the global genetic testing market reached an estimated value of about USD 19.5 Billion in 2024. With such applications of genetic screening, it becomes easier to analyze the embryo before its implantation to identify whether the child may have genetic disorders as the higher the success rates, the lesser is the probability of miscarriage. This especially works for couples with a history of genetic diseases or women who are considered advanced maternal age and are receiving IVF treatment. The high demand for PGT is further fueled by increasing awareness of the role genetics plays in reproductive health, along with continuous advances in genetic testing technology, making the procedures more precise and available. As genetic screening continues to shift, it is expected to play a significant role in improving outcomes globally and thereby impelling the market.

Rising Popularity of Fertility Preservation Techniques

The factor contributing to market growth includes the emergence of fertility preservation techniques, majorly egg freezing. Due to other professional, monetary, or personal causes, consumers are delaying parenthood, where egg and embryo freezing are coming up as preventive approaches in terms of rising fertility. Moreover, ongoing technological advancements related to the freezing process is helping eggs and embryos to thawing to a large extent. Notably, as per a study published by Oxford Press, live birth rates after embryo and oocyte cryopreservation were reported at 41% and 32%, respectively. The spontaneous LBR after tissue cryopreservation and transplantation for IVF is reported at 21% and 33%, respectively. Furthermore, increasing awareness and availability of fertility preservation services for cancer patients undergoing treatments that may affect fertility are further escalating this trend, establishing it as a crucial aspect of the shifting market landscape.

Growing Emphasis on Personalized Fertility Treatments

With advanced medical technologies and a better understanding of consumers reproductive health, fertility clinics are now moving towards customized treatment plans for each patient. Personalized IVF protocols consider the hormonal profile, genetic predispositions, and other underlying health conditions to optimize success rates by minimizing risks and improving embryo quality. This rapid shift towards customized care is particularly important for patients who may have undergone multiple failed IVF cycles, as it offers a more targeted approach. As the demand for tailored medical solutions grows, personalized fertility treatments are expected to gain further traction, offering more effective and patient-centered care in the in vitro fertilization market share.

In Vitro Fertilization Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global in vitro fertilization market, along with forecasts at the global, regional, and country levels from 2025-2033. The market has been categorized based on product, procedure type, cycle type, and end user.

Analysis by Product:

• Reagent 
  • Cryopreservation Media
  • Embryo Culture Media
  • Ovum Processing Media
  • Sperm Processing Media
• Instrument
  • Imaging Systems
  • Incubators
  • Cryosystems
  • IVF Cabinet
  • Ovum Aspiration Pump
  • Sperm Separation Systems
  • Micromanipulator Systems
  • Others
• Accessories

Instruments dominate the IVF market with 62.6% of the market share in 2024 as they play a very crucial role in ensuring the exact, efficient, and quality procedures. Such high-end instruments such as incubators, imaging systems, and micromanipulators make fertilization accurate and also enable proper embryo development, leading to a great improvement in the success rate. More recent time-lapse monitoring and automated systems minimize human errors in the procedure. The increasing demand for minimally invasive procedures and strict procedural standards creates a dependency on advanced instruments that are a need in fertility clinics and research institutions worldwide.

Analysis by Procedure Type:

• Fresh Donor
• Frozen Donor
• Fresh Non-donor
• Frozen Non-donor

The frozen non-donor segment dominates the IVF market with 59.7% of the market share in 2024, as they have a cost-effective advantage, simplicity, and more success rates compared to other treatments. Improved techniques of cryopreservation, especially vitrification, improve the chances of embryo survival during freezing and thawing processes. These cycles can be started at any time, without the necessity of synchronization between the donor and recipient. In addition, freezing the patient's own embryos completely rules out the ethical issues arising from the use of donor gametes. Additionally, awareness about the merits of frozen cycles is growing along with improvements in the freezing technologies that are making this segment increasingly popular among IVF patients.

Analysis by Cycle Type:

• Conventional IVF
• IVF with ICSI
• IVF with Donor Eggs

The IVF with intracytoplasmic sperm injection (ICSI) dominates the market with 43.0% of the market share in 2024 as it is the most effective method for treating severe male infertility and ensuring successful fertilization. ICSI involves the direct injection of a single sperm into an egg, bypassing barriers such as low sperm count, motility, or morphology issues. The precision of ICSI significantly improves fertilization rates, making it the preferred choice for complex cases. This rise in male infertility coupled with improved micromanipulation technologies further increases ICSI's supremacy as one of the most reliable and popular IVF treatments worldwide.

Analysis by End User:

• Fertility Clinics
• Hospitals
• Others

Fertility clinics dominate the IVF market with 63.9% of the market share in 2024 due to the specialized expertise, advanced facilities, and personalized care. Such clinics have the best technology, the best embryologists, and individualized treatment programs that increase the success rate. Their concentration on fertility treatments, such as IVF, donor programs, and genetic testing, makes for an all-round treatment. Moreover, growing awareness among the public along with accelerating fertility centers, results in an increase in patients choosing to go to these specialized hospitals. Their superior outcome delivery along with patient-centered care makes them the bedrock of the In Vitro Fertilization market.

Regional Analysis:

• North America
  • United States
  • Canada
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Others
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa

Europe dominates the market with 37.6% of the market share in 2024 due to favorable regulations, advanced healthcare infrastructure, and wide coverages of insurance for infertility treatments in several countries. Additionally, high adoption rates of leading-edge technologies and an extensive network of fertility clinics have attributed to its dominance. European countries also enjoy significant public awareness about the solution to infertility along with supportive cultural attitudes, which in turn is fostering the market. In addition to this, ongoing research and innovation, as well as competitive treatment costs compared to other regions, is making Europe a global hub for IVF procedures and services.

Key Regional Takeaways:
 

United States In Vitro Fertilization Market Analysis

The United States is a significant region in the North America in vitro fertilization market with a market share of 85.00%. The United States market is driven by various factors which resonate with increasing adoption of ART services and increased innovations in the realm of medical sciences. Moreover, rising cases of infertility, associated directly with delay childbearing, changed lifestyles, and rise in other medical conditions, obesity, diabetes, and hormonal disorder, is further propelling the market. According to the National Center for Health Statistics, the prevalence of total diabetes was 15.8% among U.S. adults for August 2021–August 2023. The increasing numbers of couples who are finding it difficult to conceive in the natural way are also driving the demand for IVF services. A technological advancement in the IVF procedure is improving success rates, so the appeal and accessibility open the door to a larger category of consumers. This involves innovations such as time-lapse imaging, genetic screening, and cryopreservation of embryos-all of which will improve outcomes, reduce the psychosocial stress and financial burdens on patients, and attract interest from healthcare providers and investors with better-equipped facilities and expanded services. This driving force is increasing social acceptance of IVF and other ART procedures. Socially, people's attitudes towards fertility treatments have improved and there has been more public awareness about them in mainstream media that reduces the stigma attached and prompts more consumers to look for IVF as an alternative option.

Asia Pacific In Vitro Fertilization Market Analysis

The market is majorly driven by a combination of demographics, social and technological drivers. This major trend is due to the increasing infertility levels and can be attributed to unhealthy dietary habits, stress, environmental pollution, and a rising disease burden from certain medical conditions such as polycystic ovarian syndrome (PCOS). According to the Economic Survey, unhealthy diet accounts for 54% of total diseases in India. All these leads to the rapid growth in ART, IVF, etc. Additionally, expansion of the middle class with rising incomes throughout the region makes advanced medical care, such as fertility treatment, more accessible. Also, economic growth reduces the costs and increases accessibility for a significant segment of the population toward IVF and other assisted reproduction technologies. Apart from this, governmental administrations in nations such as India, China, and Japan increasingly take fertility treatment as an essential, with more effective policies and steps to provide services under ART. Another crucial motivator is the cultural and societal trend of family and having children in most Asia-Pacific nations. The culture tends to influence consumers and couples who experience problems conceiving to turn to medical technology, thereby improving the demand for IVF. Besides, technological advancement in the IVF process, such as time-lapse imaging, preimplantation genetic testing, and improved techniques of freezing the embryo, aid in increasing the success rate. Such developments are further elevating the trust of patients towards the efficiency of IVF, which in turn are fostering market growth.

Europe In Vitro Fertilization Market Analysis

Increased infertility rates, largely due to lifestyle changes, advancing maternal age, and diseases, such as obesity, smoking, and hormonal imbalances, are driving the IVF market in Europe. As natural conception becomes impossible for most couples, assisted reproductive technologies (ART), which encompass IVF, are gaining the spotlight. Progress in medical science and techniques has been playing an important role in uplifting the IVF market in Europe. Techniques, such as PGT, cryopreservation, and improved methods of embryo culture, are improving success rates of the IVF procedures, thereby providing a viable opportunity for couples to conceive. Additionally, availability of donor eggs and sperm, combined with the rise of advanced laboratory facilities, drives the market growth further. Progressive regulatory environment and favorable insurance policies in several countries of Europe also contribute to market expansion. Most European nations have offered subsidized IVF treatments or mandate partial or full insurance coverage, which lowers the financial burden on patients and increases accessibility. Changing societal attitudes towards fertility treatments and family planning is further supporting the market growth. Moreover, Europe is a hub for medical tourism, with countries such as Spain, the Czech Republic, and Greece attracting patients worldwide due to their high-quality fertility services and competitive pricing. The research report of the IMARC Group states that the UK medical tourism market reached USD 7.83 Billion in 2023.

Latin America In Vitro Fertilization Market Analysis

The Latin America IVF market is influenced by the growing rates of infertility, changing social norms, and increased access to advanced healthcare technologies. Infertility is becoming increasingly common due to lifestyle factors, delayed childbearing, and health conditions such as obesity and stress, causing more couples to seek assisted reproductive solutions. The business-as-usual policy scenario predicts that by 2044, 75% of Brazilian adults will be overweight or obese, up from 57% in 2023. Moreover, technological advancements and the availability of cost-effective treatments in countries such as Brazil, Mexico, and Argentina are making the region a growing hub for fertility care. Improved success rates, advancements in embryo freezing, and genetic screening technologies are improving patient confidence in IVF procedures. Furthermore, social acceptance of IVF along with increased awareness about infertility treatments is reducing stigma and encouraging people and couples to explore reproductive options, thereby supporting the market further. Medical tourism also plays a crucial role, as Latin America offers affordable yet high-quality fertility services.

Middle East and Africa In Vitro Fertilization Market Analysis

Improving healthcare infrastructure and growing awareness about ART is leading the Middle East and Africa IVF market. According to a research report, the health expenditure in GCC is estimated to be around USD 135.5 Billion in 2027. The cause of infertility within the region encompasses lifestyle changes, the delayed parenthood, and health problems such as obesity and hormonal imbalances, thereby expanding the scope of IVF service demand. Apart from this, the region's governing agencies also spend on high end fertility clinics that would increase the accessibility of high-quality treatments. The UAE, Saudi Arabia, and South Africa are also crucial markets as they have more modern facilities and qualified medical personnel. Also, medical tourism in the region, especially in the UAE, is attracted to patients who want cost-effective and efficient reproductive care.

Competitive Landscape:

The in vitro fertilization (IVF) market is very competitive and constantly growing due to a rise in fertility treatment demand and advancements in reproductive technology. Infertility rates are increasing, and more and more people are delaying parenthood. This awareness about assisted reproductive techniques has become a catalyst in the market, which is full of innovation regarding treatment methods with clinics and research centers constantly focusing on bettering success rates while reducing costs. The expansion of fertility services in emerging markets, plus the ability of service providers to offer a range of individualized treatment plans to patients, further add fuel to this escalating competition. Notably, on April 24, 2024, Boston IVF announced that four of its centers have been recognized on Newsweek's 2024 list of America's Best Fertility Clinics. This recognition highlights Boston IVF's commitment to excellence in reproductive healthcare, offering a comprehensive range of fertility treatments to assist individuals and couples in achieving parenthood.

The report provides a comprehensive analysis of the competitive landscape in the In Virto Fertilization market with detailed profiles of all major companies, including:

• Boston IVF
• CooperSurgical Inc. (The Cooper Companies Inc.)
• Esco Micro Pte. Ltd
• FUJIFILM Holdings Corporation
• Genea Pty Limited
• Hamilton Thorne Ltd.
• SAFE Fertility Center
• Vitrolife AB

Latest News and Developments:

• November 2024: November 2024: India IVF secured $1.25 million in pre-Series A funding from Tomorrow Capital, marking its first external investment. This funding aims to enhance fertility care access in underserved North Indian regions through a tech-enabled platform offering comprehensive services. With the help of this new funding, India IVF will be able to expand throughout North India and close important access gaps to fertility care.
• August 2024: Birla Fertility & IVF (BFI), a Gurgaon-based company, declared its intention to open eight to twelve new centers across South and West India by FY25. The fertility care business announced its foray into Tamil Nadu, Maharashtra, and Karnataka with the purchase of 12 BabyScience IVF clinics.
• July 2024: Mira, a leading hormonal health company based in the United States, unveiled an online clinic aiming to provide personalized support to people struggling to conceive from fertility professionals. It focuses on balancing hormones, enhancing nutrition and gut health, establishing effective exercise routines, and boosting mental well-being.
• May 2024: Gameto, a biotechnology company focused on developing new treatment options for women's health, has closed an oversubscribed USD 33 Million Series B investment round, with participation from existing investors, including Insight Partners, Future Ventures, and BOLD Capital Partners led by Two Sigma Ventures with RA Capital. In the United States, funding will be provided to finish the clinical development of Fertilo-their novel investigational in vitro maturation solution of engineered OSCs to mature eggs outside of the body.

In Vitro Fertilization Market Report Scope:

Key Benefits for Stakeholders:

• IMARC’s report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the in vitro fertilization market from 2019-2033.
• The in vitro fertilization market research report provides the latest information on the market drivers, challenges, and opportunities in the global market.
• The study maps the leading, as well as the fastest-growing, regional markets. It further enables stakeholders to identify the key country-level markets within each region.
• Porter's five forces analysis assist stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the in vitro fertilization industry and its attractiveness.
• Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market.